Landmark legislation in Italy: Provisions for the treatment of rare diseases and for the support of research and production of orphan drugs
FDA approves first drug to improve growth in children with most common form of Dwarfism
NICE creates new menu of treatment options for those suffering from depression
NHS takes a bold step towards achieving net zero by decommissioning desflurane due to its high globa...
Safety signals have sparked vital discussions on patient access to ATMPs, marking a pivotal moment i...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Δ